They're getting at least what they received in dilution and loans for the entire last year. I don't get where you're coming from as far as saying "but it's not news that ensures the whole process as Linda P says". That's akin to calling her a liar, is it not?
They needed funds to start the other trials and finish the P3. They got it. Of course they're going to continue needing to raise money until they're selling the product. Even then they'll need new funding to finish other trials, etc.
So, either they plan on a big PPS increase as top line is announced, new trials are started, Joint Ventures are announced, etc. or...what? What is your point?
Market Data 
Markets 
